Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Anti-human IgM monoclonal antibody, hybridoma cell strain and application thereof

A hybridoma cell line, monoclonal antibody technology, applied in biochemical equipment and methods, material testing products, instruments, etc., can solve the problem of systematic evaluation of cross-reactivity, stability, detection sensitivity and specificity, antibody Whether it is suitable for the preparation of in vitro diagnostic reagents is unclear, the specificity of polyclonal antibodies is low, etc., to achieve the effects of excellent long-term and thermal stability, best immune effect, loose storage conditions and operating conditions

Active Publication Date: 2018-08-10
SICHUAN ANKERUI NEW MATERIAL TECH CO LTD
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In recent years, there have been some studies on anti-human IgM monoclonal antibodies. For example, a patent document WO 2010026758 A1 discloses an anti-human IgM monoclonal antibody. This patent aims to solve the problem of low specificity of polyclonal antibodies, and focuses on The nature of the monoclonal antibody-induced agglutination between human IgM and its effect of inhibiting non-specific reactions were verified, but no attention was paid to the systematic evaluation of the anti-human IgM monoclonal antibody when it was used in in vitro diagnostic reagents (eg, antibody potency). valence, cross-reactivity, stability, detection sensitivity and specificity, etc.), therefore, whether the antibody is suitable for the preparation of in vitro diagnostic reagents is not clear
[0005] Another example is the anti-human IgM monoclonal antibody of Xiamen Bosheng Biotechnology Co., Ltd., which is a common commercial anti-human IgM monoclonal antibody, but its stability is not good, so it has shortcomings when used in immunodiagnostic antibodies

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-human IgM monoclonal antibody, hybridoma cell strain and application thereof
  • Anti-human IgM monoclonal antibody, hybridoma cell strain and application thereof
  • Anti-human IgM monoclonal antibody, hybridoma cell strain and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0067] The immunization of embodiment 1 mice

[0068] Dilute the human IgM extracted from the blood source (Sichuan Mike Bio-New Materials Technology Co., Ltd., batch number 150127) to 1.0 mg / ml with normal saline, and mix it with the quick-immune adjuvant QuickAntibody 5w (Beijing Boaolong Immunology Technology Co., Ltd.) , mix well, and give BALB / c mice (Chengdu Dashuo Experimental Animal Center, 6-week-old female, 2 mice) with a dose of 50 μl / limb intramuscular injection, and boost immunity 21 days after the first immunization, method and dosage Same as before, after 35 days, the tail blood was collected, the serum was separated, and the titer was determined by indirect ELISA method, and the titer of all mouse serum was greater than 1:10 6 , which can be used for fusion. Three days before the fusion, human IgM was diluted to 1.0 mg / ml with normal saline, and then mixed with normal saline in equal volume for booster immunization through the tail vein, with a dose of 50 μl p...

Embodiment 2

[0069] The preparation of embodiment 2 hybridoma cell lines

[0070] 2-1 Preparation of feeder cells

[0071] Peritoneal macrophages of normal 10-week-old BALB / c mice were used as feeder cells. One day before the fusion, BALB / c was killed by taking blood from the eyes, soaking in 0.1% bromogeramine for 1 minute, then soaking in 75% alcohol for 1 minute, and cutting the abdominal skin with scissors under aseptic operation in the ultra-clean bench to expose the peritoneum. Inject 4.5ml of RPMI1640 basal culture solution into the peritoneal cavity with a syringe, then take it out with a dropper, then add 5.5ml RPMI1640 basal culture solution to wash repeatedly, recover the washing solution, centrifuge at 1000rpm for 5 minutes, and use RPMI1640 with 20% newborn bovine serum The culture medium was resuspended, and the cell concentration was adjusted to 3.2×10 5 cells / ml, added to 96-well plate, 100 μl / well, 37°C, 5% CO 2 to cultivate.

[0072] 2-2 Preparation of immune splenocy...

Embodiment 3

[0082] The preparation of embodiment 3 monoclonal antibody

[0083] Choose healthy BALB / c mice of 6-8 weeks, inject 0.5ml liquid paraffin (Tianjin Kemiou) into each mouse intraperitoneally, and inject 1.1×10 6 a hybridoma cell. Ascites can be produced 7 to 10 days after inoculation of the cells. Closely observe the health status and signs of ascites of the animals. When ascites is as large as possible, and before the mice are about to die, the mice are killed, and the ascites is sucked into the test tube with a dropper. One mouse 1 ~ 5ml ascites can be obtained. The collected ascites was centrifuged to obtain the supernatant, and a small sample was taken and stored in a -20°C refrigerator. After the ascitic fluid was saturated and precipitated with ammonium sulfate, it was purified with a protein A affinity chromatography column. The purity of the antibody detected by SDS-PAGE was greater than 90% (denoted as IgM-Ab10). The electrophoresis results were as follows: figure 1 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a hybridoma cell strain and a monoclonal antibody secreted by the hybridoma cell strain. The antibody can realize the specific combination with the human IgM, can be used forhuman IgM in-vitro detection, and is particularly suitable for being used for early diagnosis of hepatitis B virus. The invention also comprises a kit comprising the hybridoma cell strain or the monoclonal antibody.

Description

technical field [0001] The present invention relates to a monoclonal antibody, in particular to an anti-human IgM monoclonal antibody. Background technique [0002] Immunodiagnostic reagents are one of the main types of in vitro diagnostic reagents. It utilizes the specific reaction of the combination of antigen and antibody to perform qualitative or quantitative diagnosis. Whether it is technology or market, this type of reagent is the fastest growing among all diagnostic reagent products at present. [0003] After pathogenic microorganisms infect the human body, IgM antibodies are first produced during the stimulation-induced humoral immune response. Early diagnosis of infectious diseases is the prerequisite for early and effective treatment, especially for infectious diseases with acute onset and dangerous conditions. , early diagnosis is particularly important, because the first antibody that appears in the body after infection is IgM antibody, so the detection of speci...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/20C07K16/42G01N33/68G01N33/569C12R1/91
CPCC07K16/4283G01N33/56983G01N33/686
Inventor 黄家菊王磊舒川李岚敏何涛龙腾镶
Owner SICHUAN ANKERUI NEW MATERIAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com